CCR5 RECEPTOR ANTAGONIST MOLECULES

The invention is directed to komaroviquinone, compound 1, 4 rings, heterocyclic (6,5,6,6-ring system), as CCR5 receptor antagonist, and to a pharmaceutical formulation comprising compound 1. The invention further relates to a use of the pharmaceutical composition comprising CCR5 receptor antagonist...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	WILLIAMS, ROBERT, D, FAWZI, AHMAD, LAHLOU, EL HASSANE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!